88 related articles for article (PubMed ID: 11527393)
1. Metastin suppresses the motility and growth of CHO cells transfected with its receptor.
Hori A; Honda S; Asada M; Ohtaki T; Oda K; Watanabe T; Shintani Y; Yamada T; Suenaga M; Kitada C; Onda H; Kurokawa T; Nishimura O; Fujino M
Biochem Biophys Res Commun; 2001 Sep; 286(5):958-63. PubMed ID: 11527393
[TBL] [Abstract][Full Text] [Related]
2. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor.
Ohtaki T; Shintani Y; Honda S; Matsumoto H; Hori A; Kanehashi K; Terao Y; Kumano S; Takatsu Y; Masuda Y; Ishibashi Y; Watanabe T; Asada M; Yamada T; Suenaga M; Kitada C; Usuki S; Kurokawa T; Onda H; Nishimura O; Fujino M
Nature; 2001 May; 411(6837):613-7. PubMed ID: 11385580
[TBL] [Abstract][Full Text] [Related]
3. Cleavage of metastasis suppressor gene product KiSS-1 protein/metastin by matrix metalloproteinases.
Takino T; Koshikawa N; Miyamori H; Tanaka M; Sasaki T; Okada Y; Seiki M; Sato H
Oncogene; 2003 Jul; 22(30):4617-26. PubMed ID: 12879005
[TBL] [Abstract][Full Text] [Related]
4. Metastin and its variant forms suppress migration of pancreatic cancer cells.
Masui T; Doi R; Mori T; Toyoda E; Koizumi M; Kami K; Ito D; Peiper SC; Broach JR; Oishi S; Niida A; Fujii N; Imamura M
Biochem Biophys Res Commun; 2004 Feb; 315(1):85-92. PubMed ID: 15013429
[TBL] [Abstract][Full Text] [Related]
5. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.
Shoji S; Tang XY; Umemura S; Itoh J; Takekoshi S; Shima M; Usui Y; Nagata Y; Uchida T; Osamura RY; Terachi T
Eur Urol; 2009 Feb; 55(2):441-9. PubMed ID: 18395325
[TBL] [Abstract][Full Text] [Related]
6. Effects of a KiSS-1 peptide, a metastasis suppressor gene, on the invasive ability of renal cell carcinoma cells through a modulation of a matrix metalloproteinase 2 expression.
Yoshioka K; Ohno Y; Horiguchi Y; Ozu C; Namiki K; Tachibana M
Life Sci; 2008 Aug; 83(9-10):332-8. PubMed ID: 18644390
[TBL] [Abstract][Full Text] [Related]
7. Effect of platelet-activating factor receptor expression on CHO cell motility.
Boccellino M; Biancone L; Cantaluppi V; Ye RD; Camussi G
J Cell Physiol; 2000 May; 183(2):254-64. PubMed ID: 10737901
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship study on small peptidic GPR54 agonists.
Tomita K; Niida A; Oishi S; Ohno H; Cluzeau J; Navenot JM; Wang ZX; Peiper SC; Fujii N
Bioorg Med Chem; 2006 Nov; 14(22):7595-603. PubMed ID: 16879969
[TBL] [Abstract][Full Text] [Related]
9. KiSS-1 expression and metastin-like immunoreactivity in the rat brain.
Brailoiu GC; Dun SL; Ohsawa M; Yin D; Yang J; Chang JK; Brailoiu E; Dun NJ
J Comp Neurol; 2005 Jan; 481(3):314-29. PubMed ID: 15593369
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of cell surface plasminogen activation by membrane-bound melanotransferrin: a key phenomenon for cell invasion.
Michaud-Levesque J; Demeule M; Béliveau R
Exp Cell Res; 2005 Aug; 308(2):479-90. PubMed ID: 15936756
[TBL] [Abstract][Full Text] [Related]
11. KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity.
Stathatos N; Bourdeau I; Espinosa AV; Saji M; Vasko VV; Burman KD; Stratakis CA; Ringel MD
J Clin Endocrinol Metab; 2005 Sep; 90(9):5432-40. PubMed ID: 15998767
[TBL] [Abstract][Full Text] [Related]
12. Cancer metastasis-suppressing peptide metastin upregulates excitatory synaptic transmission in hippocampal dentate granule cells.
Arai AC; Xia YF; Suzuki E; Kessler M; Civelli O; Nothacker HP
J Neurophysiol; 2005 Nov; 94(5):3648-52. PubMed ID: 16222076
[TBL] [Abstract][Full Text] [Related]
13. Metastin (KiSS-1) mimetics identified from peptide structure-activity relationship-derived pharmacophores and directed small molecule database screening.
Orsini MJ; Klein MA; Beavers MP; Connolly PJ; Middleton SA; Mayo KH
J Med Chem; 2007 Feb; 50(3):462-71. PubMed ID: 17266198
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of downsized metastin (45-54) analogs with maintenance of high GPR54 agonistic activity.
Niida A; Wang Z; Tomita K; Oishi S; Tamamura H; Otaka A; Navenot JM; Broach JR; Peiper SC; Fujii N
Bioorg Med Chem Lett; 2006 Jan; 16(1):134-7. PubMed ID: 16242330
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells.
Yamaguchi H; Kitayama J; Takuwa N; Arikawa K; Inoki I; Takehara K; Nagawa H; Takuwa Y
Biochem J; 2003 Sep; 374(Pt 3):715-22. PubMed ID: 12803545
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of mouse metastasis-suppressor KiSS1 and its G-protein-coupled receptor.
Stafford LJ; Xia C; Ma W; Cai Y; Liu M
Cancer Res; 2002 Oct; 62(19):5399-404. PubMed ID: 12359743
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of plasma metastin level in pancreatic cancer patients.
Katagiri F; Nagai K; Kida A; Tomita K; Oishi S; Takeyama M; Doi R; Fujii N
Oncol Rep; 2009 Mar; 21(3):815-9. PubMed ID: 19212644
[TBL] [Abstract][Full Text] [Related]
18. Expression of metastin and a G-protein-coupled receptor (AXOR12) in epithelial ovarian cancer.
Hata K; Dhar DK; Watanabe Y; Nakai H; Hoshiai H
Eur J Cancer; 2007 Jun; 43(9):1452-9. PubMed ID: 17442564
[TBL] [Abstract][Full Text] [Related]
19. Europium-labeled epidermal growth factor and neurotensin: novel probes for receptor-binding studies.
Mazor O; Hillairet de Boisferon M; Lombet A; Gruaz-Guyon A; Gayer B; Skrzydelsky D; Kohen F; Forgez P; Scherz A; Rostene W; Salomon Y
Anal Biochem; 2002 Feb; 301(1):75-81. PubMed ID: 11811969
[TBL] [Abstract][Full Text] [Related]
20. TG1019/OXE, a Galpha(i/o)-protein-coupled receptor, mediates 5-oxo-eicosatetraenoic acid-induced chemotaxis.
Hosoi T; Sugikawa E; Chikada A; Koguchi Y; Ohnuki T
Biochem Biophys Res Commun; 2005 Sep; 334(4):987-95. PubMed ID: 16039985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
